Hepatitis B virus DNA–positive, hepatitis B surface antigen–negative blood donations intercepted by anti‐hepatitis B core antigen testing: the Canadian Blood Services experience
- 19 July 2007
- journal article
- Published by Wiley in Transfusion
- Vol. 47 (10) , 1809-1815
Abstract
BACKGROUND: The benefit of introducing anti‐hepatitis B core antigen (HBc) screening for intercepting potentially infectious donations missed by hepatitis B surface antigen (HBsAg) screening in Canada was studied.STUDY DESIGN AND METHODS: Anti‐HBc testing of all donations was implemented in April 2005, along with antibody to hepatitis B surface antigen (anti‐HBs) and hepatitis B virus (HBV) DNA supplemental testing of anti‐HBc repeat‐reactive, HBsAg‐negative donations. The proportion of potentially infectious donations intercepted by anti‐HBc over the initial 18 months of testing was calculated based on three assumptions relating infectivity of HBV DNA–positive units to anti‐HBs levels. Lookback was conducted for all DNA‐positive donations.RESULTS: Of 493,344 donors, 5,585 (1.13%) were repeat‐reactive for the presence of anti‐HBc, with 29 (0.52%) being HBV DNA–positive and HBsAg‐negative. The proportion of potentially infectious donations intercepted by anti‐HBc screening was 1 in 17,800 if all HBV DNA–positive donations were infectious, 1 in 26,900 if infectivity was limited to donations with an anti‐HBs level of not more than 100 mIU per mL, and 1 in 69,300 if only donations with undetectable anti‐HBs were infectious. For 279 components in the lookback study, no traced recipients were HBsAg‐positive and 7 recipients were anti‐HBc–reactive in association with 4 donors, 3 of whom had an anti‐HBs level of more than 100 mIU per mL and 1 of whom had a level of 61 mIU per mL.CONCLUSION: Implementation of anti‐HBc screening reduced the risk of transfusing potentially infectious units by at least as much as had been expected based on the literature. The lookback did not provide proof of transfusion transmission of HBV from HBV DNA–positive, anti‐HBc–reactive, HBsAg‐negative donors but it did not establish lack of transmission either.Keywords
This publication has 21 references indexed in Scilit:
- New Strategies for Blood Donor Screening for Hepatitis B VirusMolecular Diagnosis & Therapy, 2006
- Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV testTransfusion, 2005
- Endpoints in clinical trials on transfusion requirements: the need for a structured approachTransfusion, 2005
- Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti‐HBc: implications for transfusion transmission and donor screeningTransfusion, 2003
- Risks associated with transfusion of cellular blood components in canadaTransfusion Medicine Reviews, 2003
- HBV: amplified and back in the blood safety spotlightTransfusion, 2001
- Comparison of the sensitivity of NAT using pooled donor samples for HBV and that of a serologic HBsAg assayTransfusion, 2001
- Analysis of HBV infection after blood transfusion in Japan through investigation of a comprehensive donor specimen repositoryTransfusion, 2001
- Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipientsTransfusion, 1995
- Posttransfusion Fulminant Hepatitis B Associated with Precore-Defective HBV MutantsVox Sanguinis, 1991